KRYS Krystal Biotech, Inc. | US5011471027
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 9.881.319.424 | 7.604.166.055,6 | 7.196.995.484,01 | 5.116.545.484,62 |
| Enterprise Value | 9.067.026.432 | 7.111.965.055,6 | 6.710.030.484,01 | 4.733.452.484,62 |
| Trailing P/E | 44,81 | 33,79 | 35,14 | 33,35 |
| Forward P/E | 33,96 | - | - | - |
| Price to Sales | 23,68 | 18,22 | 18,5 | 18,14 |
| Price to Book | 7,73 | 5,96 | 5,9 | 4,5 |
| EV/Revenue | 21,73 | 17,04 | 17,24 | 16,78 |
| EV/EBITDA | 50,24 | 38,38 | 40 | 38,89 |